H a l f -Ye a r Re p o r t 2 0 1 9
Ta b l e o f C o nte nt s
Share and Bond Information | 4 |
Letter to the Shareholders | 6 |
Portfolio Companies | 10 |
Consolidated Financial Statements | 16 |
CHF 501M
TOTAL REVENUE
STRONGLY UP
45.9%
EBITDA
MARGIN
CHF 202M
PROFIT
Investing for a better life
AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastruc- ture. AEVIS VICTORIA′s main shareholdings are Swiss Medical Network SA, the second largest group of private hospitals in Switzerland, Victoria-Jungfrau Collection AG, a luxury hotel group managing four luxury hotels in Switzerland, Infracore SA (19%), a real estate company dedicated to healthcare-related infrastructure, a hospitality real estate division, Medgate (40%), the leading telemedicine provider in Switzerland, and NESCENS SA, a brand dedicated to better aging. AEVIS VICTORIA is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW).
www.aevis.com
Key Figures
(In thousands of CHF | HY 2018 | ||
unless otherwise stated) | HY 2019 | (restated) | FY 2018 |
3
Key Figures
FOR THE PERIOD
CHF 998M
MARKET CAPITALISATION
Total revenue | 545'587 |
Net revenue | 501'182 |
EBITDAR* | 241'676 |
EBITDAR margin | 48.2% |
EBITDA | 229'988 |
EBITDA margin | 45.9% |
EBIT | 201'083 |
EBIT margin | 40.1% |
Profit/(loss) for the period | 202'118 |
Market price per share at end of period (in CHF) | 12.70 |
Number of outstanding shares | 78'576'061 |
Market capitalisation | 997'916 |
319'125 657'205
280'566 577'028
38'828 84'682
13.8% 14.7%
31'807 70'088
11.3% 12.1%
5'926 16'672
2.1% 2.9%
(1'571) (6'615)
11.80 12.20 77'803'630 77'419'205
918'083 944'514
Half-Year Report 2019 l
* Earnings before interest, taxes, depreciation, amortisation and rental expenses
For a better comparability, the market figures in the table above have been retrospectively adjusted to take the 1:5 share split into account.
Share and Bond Information
Number of Shares
30.06.2019 | 31.12.2018 | |||
Share Register | Share capital (in CHF) | 78'591'035 | 78'591'035 | |
Computershare Schweiz AG | Number of registered shares issued | 78'591'035 | 78'591'035 | |
Tel. +41 62 205 77 00 | Nominal value per registered share (in CHF) | 1 | 1 | |
share.register@computershare.ch | Number of treasury shares | 14'974 | 1'171'830 | |
Number of registered shares outstanding | 78'576'061 | 77'419'205 | ||
Data per Share
(in CHF unless otherwise stated) | 30.06.2019 | 31.12.2018 |
Media & Investor Relations c/o Dynamics Group AG Philippe Blangey
Tel. +41 43 268 32 32
investor.relations@aevis.com
EBITDA per share | 2.93 | 0.91 | |
High | 13.40 | 12.56 | |
Low | 11.60 | 11.44 | |
End price | 12.70 | 12.20 | |
Average volume per day (in units) | 38'075 | 27'568 | |
Market capitalisation | 997'915'975 | 944'514'301 | |
On 27 May 2019, the General Meeting of the Company approved the split of one existing share into five new shares. For a better comparability, the figures in the tables above have been retrospectively adjusted for 2018. The historical stock market prices were adjusted by the SIX Swiss Exchange.
4
Half-YearReport 2019 l Share and Bond Information
Share Price Performance
CHF
14
AEVIS SPI
13.5
13
12.5
12
11.5
11
10.5
10
Jan Feb Mar Apr May Jun Jul | Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep |
2018 | 2019 |
The registered shares of AEVIS VICTORIA SA are traded on the Swiss Reporting
Standard of SIX Swiss Exchange and are part of the Swiss Performance Index
SPI, the SXI Life Sciences Index (SLIFE) and the SXI Bio+Medtech Index (SBIOM).
Valor symbol: | AEVS | Bloomberg: | AEVS SW Equity |
Valor no.: | 47863410 | Reuters: | AEVS.S. |
ISIN: | CH0478634105 | ||
AEVIS VICTORIA SA Bonds
AEVIS VICTORIA SA has issued three fixed rate bonds shown in the table below.
AEV16 | AEV161 | AEV18 | ||||||||||||||||||||||
Bond type | Fixed rate | Fixed rate | Fixed rate | |||||||||||||||||||||
Nominal amount | CHF 150.0 million | CHF 145.0 million | CHF 55.0 million | |||||||||||||||||||||
Securities number | CH0325429162 | CH0337829276 | CH0420465954 | |||||||||||||||||||||
Interest rate | 2.50% | 2.00% | 2.25% | |||||||||||||||||||||
Term | 07.06.2016 to 07.06.2021 | 19.10.2016 to 19.10.2022 | 29.06.2018 to 29.06.2020 | |||||||||||||||||||||
Maturity | 07.06.2021 at par value | 19.10.2022 at par value | 29.06.2020 at par value | |||||||||||||||||||||
CHF | ||||||||||||||||||||||||
107 | ||||||||||||||||||||||||
AEV 16 | AEV 161 | AEV 18 | ||||||||||||||||||||||
106 | ||||||||||||||||||||||||
105 | ||||||||||||||||||||||||
104 | ||||||||||||||||||||||||
103 | ||||||||||||||||||||||||
102 | ||||||||||||||||||||||||
101 | ||||||||||||||||||||||||
100 | ||||||||||||||||||||||||
99 | ||||||||||||||||||||||||
98 | 5 | |||||||||||||||||||||||
Jun | Dec | Jun | Dec | Jun | Dec | Jun | ||||||||||||||||||
2016 | 2017 | 2018 | 2019 | |||||||||||||||||||||
Information | ||||||||||||||||||||||||
Major Shareholders | ||||||||||||||||||||||||
The following shareholders held more than 3% on 30 June 2019: | and Bond | |||||||||||||||||||||||
Group A. Hubert / M. Reybier / M.R.S.I. Medical Research, | 75.87% | |||||||||||||||||||||||
Services and Investments SA | Share | |||||||||||||||||||||||
Medical Properties Trust, Inc. | 4.90% | |||||||||||||||||||||||
l | ||||||||||||||||||||||||
Kuwait Investment Office as agent for the Government | 3.39% | 2019 | ||||||||||||||||||||||
of the State of Kuwait | ||||||||||||||||||||||||
Report | ||||||||||||||||||||||||
Total shareholders (30 June 2019) | 1'671 | |||||||||||||||||||||||
Financial Reporting | Half-Year | |||||||||||||||||||||||
November 2019 | Publication of 3Q 2019 Revenue | |||||||||||||||||||||||
February 2020 | Publication of 2019 Revenue | |||||||||||||||||||||||
27 March 2020 | Publication of the 2019 Annual Results | |||||||||||||||||||||||
May 2020 | Publication of 1Q 2020 Revenue | |||||||||||||||||||||||
30 April 2020 | Ordinary general shareholders meeting for the year 2019 | |||||||||||||||||||||||
18 September 2020 | Publication of the 2020 Half-Year Results | |||||||||||||||||||||||
November 2020 | Publication of 3Q 2020 Revenue | |||||||||||||||||||||||
Pour lire la suite de ce noodl, vous pouvez consulter la version originale ici.
Attachments
- Original document
- Permalink
Disclaimer
AEVIS Victoria SA published this content on 13 September 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 September 2019 05:31:03 UTC